KAUST researchers have developed a CRISPR-Cas system using a heat-stable Cas13 protein (TccCas13a) from Thermoclostridium caenicola, compatible with RT-LAMP for rapid viral detection. The new assay, named OPTIMA-dx, enhances the specificity of RT-LAMP tests by reducing false positives in SARS-CoV-2 detection. The team, led by Dr. Magdy Mahfouz and doctoral student Ahmed Mahas, is transitioning the product to a startup phase for commercialization. Why it matters: This innovation could significantly improve point-of-care diagnostics for COVID-19 and other infections by providing a more accurate and easier-to-use testing method.
KAUST researchers are developing iSCAN, a rapid, field-deployable COVID-19 test using RT-LAMP coupled with CRISPR-Cas12. The iSCAN system is designed for rapid, specific detection of SARS-CoV-2 and can be deployed by untrained personnel. The researchers are benchmarking iSCAN against commercial kits and seeking emergency use authorization from the Saudi FDA. Why it matters: A rapid, accurate, and field-deployable COVID-19 test could significantly improve pandemic management and control in Saudi Arabia and beyond.
KAUST researchers developed a laser-based sensor that exploits the "chirp" phenomenon in semiconductor lasers to accurately measure gas temperature in combustion systems. The sensor uses spectroscopic measurements at very fast rates (1.0 MHz) and can measure temperature at the nanosecond timescale at repetition rates of thousands of kHz. The new sensor reduces uncertainty compared to previous methods and works rapidly in transient shock tube experiments. Why it matters: This in-house development provides a non-invasive, accurate, and easily implementable system for combustion research, with implications for understanding and improving energy efficiency.
KAUST Research Scientist Dr. Ram Karan received a Young Scientist Award at the 15th International Congress on Thermophiles in Japan for his work on extremozymes from Red Sea brine pools. His research focuses on identifying, purifying, and bioengineering microbial proteins from these pools. He utilizes single-amplified genomes (SAGs) to produce extremozyme proteins without needing to grow cells in the lab. Why it matters: This award recognizes KAUST's innovative research into extremophiles, which have the potential to develop novel, sustainable biotechnical processes for industrial applications.
KAUST's Rapid Research Response Team (R3T), including Professor Samir Hamdan, is working to understand and counteract the spread of COVID-19. The team assembled a complete homemade, one-step RT-PCR test, comparable to commercial kits, with a patent-free manufacturing recipe. KAUST R3T is also researching faster, more accurate point-of-care tests, including a CRISPR-based molecular test. Why it matters: This research provides accessible testing solutions and contributes to more effective and rapid detection methods for combating viral spread in the region and globally.